The largest database of trusted experimental protocols

Opti memtm

Manufactured by Thermo Fisher Scientific
Sourced in United States, China

Opti-MEMTM is a cell culture medium designed to support the growth and maintenance of a variety of cell lines. It is a serum-free, low-protein formulation that provides essential nutrients and growth factors to help maintain cell viability and proliferation.

Automatically generated - may contain errors

50 protocols using opti memtm

1

Transfection and Silencing of TIMAP and MYPT1

Check if the same lab product or an alternative is used in the 5 most similar protocols
For transfection with His6- or GFP-TIMAP cDNA, COS7 cells in the logarithmic phase of replication were transfected with Lipofectamine 2000® (Life Technologies) and 4 μg of plasmid cDNA per 35-mm plate. Cells were used 48 h after transfection. His6- and GFP-TIMAP protein expression was verified by WB analysis.
To silence TIMAP or MYPT1 expression, ECs were plated in 35-mm culture dishes at ∼60% confluence. 24 h later, the medium was replaced with 1 ml of EBM-2 lacking antibiotics. 60 pmol of control, 60 pmol of hTIMAP-specific siRNA, or 30 and 60 pmol of control or hMYPT1-specific siRNA were added to 100 μl of Opti-MEMTM (Gibco) combined with 6 μl of Lipofectamine 3000® in 100 μl of Opti-MEMTM, incubated for 5 min at room temperature, and then added to 1.0 ml of EBM-2 medium in each 35-mm dish. 6 h later, 1.0 ml of EBM-2 medium containing 10% FBS (no antibiotics) was added, and the cells were harvested 48 h after addition of siRNA.
+ Open protocol
+ Expand
2

Lipoplex Formulation for GFP Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
All lipoplex formulations were prepared following the manufacturer’s recommended protocol. Briefly, we first prepared the two pre-solutions: 3.6 μl of Lipofectamine 3000 reagent mixed into 60 μl of Opti-MEMTM by pipetting (pre-solution 1), and 4.8 μl of P3000 reagent along with 2,400 ng of pGFP mixed into 60 μl of Opti-MEMTM (Fisher Scientific) by pipetting (pre-solution 2). Lipoplexes were formed by mixing pre-solution 1 and 2, followed by incubation for 15 min at room temperature before use.
+ Open protocol
+ Expand
3

FUS and TDP-43 aggregation dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded on poly-L-lysine−coated coverslips (2.5 × 105 cells) one day prior to the experiment. When ∼ 50% confluency was reached, cells were transiently transfected with 1 µg FUS-GA, 1 µg FUS-B, and 1 µg TDP-43-RA via 6 µl lipofection (X-TremeGene 9, Roche) in 300 µl Opti-MEMTM (Life Technologies), or 1 µg tandem plasmid CMV-FUS-GA-IRES-FUS-B-IRES-TDP-43-RA via 2 µl lipofection in 100 µl Opti-MEMTM. Proteins were transiently expressed for 24 h at 37 °C under 5% CO2 in a HERAcell Vios 160i LK CO2 incubator (Thermo Fisher Scientific). Cells were treated with 25 µM AdOx (Selleck Chem) for 24 h and stained with 1 µM Hoechst 33342 (Enzo) for 10 min before confocal imaging. Cells transfected with 1 µg TDP-43-GA and 1 µg TDP-43-B or 1 µg TDP-43-eGFP only were treated with 5 µM CuET (TCI) for 3 h before imaging. All confocal images of cells were got with Leica Stellaris 5 High-resolution Laser Confocal Fluorescence Microscope.
+ Open protocol
+ Expand
4

In vitro Transwell Migration Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro migration assays were carried out using 6.5 mm Transwell plates with 5.0 μm pore polycarbonate membrane inserts (Corning, Torino, Italy). Uninfected and infected THP-1 cells and primary human monocytes (in both cases 105 cells) were suspended in 100 µL serum-free medium (OptiMEMTM, Gibco) and seeded in the inserts, while 600 µL of serum-free medium alone or serum-free medium in which cancer cells had been cultured were placed in the well. Transwell plates were incubated for 3 h at 37 °C in a 5% CO2 atmosphere with 98% humidity. Inserts were removed and migrated cells were stained with CellTracker™ Red CMTPX Dye (Invitrogen) following the manufacturer’s instructions and were counted over at least three different 10× microscopy fields.
+ Open protocol
+ Expand
5

Overexpression and Knockdown of Circular RNAs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To construct the overexpression plasmids of circPTPRA, LMNB1, EIF4A3, and FUS, the synthetic human circPTPRA cDNA was cloned into the pLC5‐ciR vector by Geneseed Biotech Co., Ltd., the synthetic human LMNB1, EIF4A3, and FUS cDNAs were cloned into the pEX‐3 vector by GenePharma, and the empty plasmid was used as a control. The siRNA sequences of circPTPRA, LMNB1, EIF4A3, and FUS, as well as the mimics and inhibitor of miR‐140‐5p were designed and synthesized by RiboBio Co., Ltd. LipofectamineTM 3000 (Invitrogen) and Opti‐MEMTM (Gibco) were used as transient transfection reagents according to the manufacturer's instruction. Total RNA was extracted 48 h after transfection. The sequences of siRNAs, sh‐RNAs, plasmids, mimics and inhibitors are shown in Additional file 1 Table S1.
The overexpression and knockdown lentiviruses of circPTPRA and LMNB1 were constructed by Genechem Co., Ltd. Lentiviral infection was performed according to the manufacturer's instruction. Stable transfected cells were selected by culturing in medium containing 5 μg/mL puromycin (Beyotime), and the expression of circPTPRA and LMNB1 was confirmed by quantitative real‐time PCR (qRT–PCR).
+ Open protocol
+ Expand
6

FASN Knockdown in Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 60 mm dishes at a density of 5 × 104 cells/ml. 24h post-seeding, cells were transfected with siRNA against fatty acid synthase (FASN, Santa Cruz, SC-41516, 17 pmol), using lipofectamine (RNAiMAX, ThermoFisher) as the transfection reagent and Opti-MEMTM (GibcoTM) as the transfection medium. Control siRNA (Qiagen, 1027280) was used as a negative control. Cells were harvested 24h post-transfection and seeded into appropriate dishes for further study. Transfection efficiency was determined via immunoblotting against FASN (1/1000, Cell Signaling Technology, #3189).
+ Open protocol
+ Expand
7

Transfection and RNA/IF Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patient-derived clones were transfected in HEK 293T cells in a 1:3 dilution of DNA: Fugene (Promega, United States) using 1 μg DNA for 24 h. All transfection reagents were mixed in Opti-MEMTM (Gibco, Life Technologies, Carlsbad, United States) to a proportion of 1:10 of total media volume of RPMI. After 24 h post-transfection, media was removed and cells washed twice in PBS prior fixation using 10% NBF for 20 min at RT. Subsequently, RNAscope was performed and IF using primary and secondary antibody staining. Images were acquired using single point scanning confocal microscopy.
+ Open protocol
+ Expand
8

Extracellular Vesicle Purification and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
EVs were purified according to differential centrifugation protocols, with slight modification [71 ]. WT BMDM and gorasp2−/- BMDM from C57BL/6 were seeded in culture dishes in complete DMEM containing 8% L929 culture supernatant, at approximately 70% confluence. After washing with DPBS (Gibco, A1285801), the cells were incubated in OPTI-MEMTM (Gibco, 31,985,088) with 250 ng/mL LPS for 24 h. In WT MEF and atg5−/- MEF cells were washed with DPBS and incubated in EBSS medium for 14 h with 20 nM Baf and 20 μM CQ. The supernatants were harvested and centrifuged at 300 × g for 10 min to remove the cell debris. The supernatants were centrifuged at 2,000 × g for 20 min to remove apoptotic bodies and then at 10,000 × g for 30 min to remove large particles. Finally, the supernatants were ultracentrifuged at 100,000 × g for 2 h, and the pellets (EVs) were resuspended in DPBS. Protein concentration was measured using the BCA protein assay kit (Thermo Fisher Scientific, 23,225). The same amount of EVs from each sample was incubated with 20 μg/mL proteinase K (New England BioLabs, P8107S), with or without 1% Triton X-100, for 1 h at 37°C. The reaction was stopped by adding 2× protein sample buffer, and the lysates were immunoblotted.
+ Open protocol
+ Expand
9

Packaging and Transducing Retro- and Lentiviruses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Retrovirus and lentivirus were packaged as follows. 293FT cells were plated on 6-well plates at roughly 50% confluence in full-growth medium and 16–24 h later were transfected with a mixture of 1 μg of viral vector, 0.5 μg of packaging vector (pCL-eco or gag/pol for retrovirus, psPAX2 for lentivirus), 0.5 μg of coat protein (VSVG or pHCMV-EcoEnv), 5 μl of X-tremeGENETM 9 (Sigma), and 95 μl of Opti-MEMTM (Gibco). The transfection mix was prepared using the manufacturer's protocol and added to the cells for 16–24 h, after which the mix was removed and the cells were fed with fresh full-growth medium. Cells were then cultured for an additional 24 h, after which the culture supernatant was collected and filtered through a 0.45-μm filter and then either stored at −80 °C or immediately used. For stable transduction, cells were plated at roughly 50% confluence, and then, 16–24 h later, viral supernatant diluted 1:1 with fresh growth medium was added to the cells. Polybrene (Sigma) was also added at 8 μg/ml. After 24 h, viral supernatants were removed, and cells were fed with fresh growth medium and then stably selected with the appropriate antibiotic.
+ Open protocol
+ Expand
10

C6 Glioma Cell NMDA Receptor Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat C6 glioma cells were gifted by Dr Nathalie Chevalier (INSERM U1198). They were maintained in DMEM supplemented by 10% fetal calf serum in the presence of 100 U/ml penicillin and 100 μg/ml streptomycin. C6 cells were transfected at 80% confluence with a combination of GluN1 and GluN2A or GluN2B (3.75 µg cDNA/wells) + 10 µl of Lipofectamine (Invitrogen) diluted in Opti-MEMTM (GibcoTM). The cells were used 24 h after transfection. All constructions of NMDA receptor subunits have been kindly provided by Pierre Paoletti (IBENS, ENS, Paris). C6 cells were used for less than 15 passages.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!